Clinical Trials in Lancaster, United States
Locations / Lancaster, United States
Delta Trials records 1,480 clinical trials conducted in Lancaster, United States, making it a notable site of clinical research activity. These trials across 2,108 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 173 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Lancaster has changed over time.
1480
Total Trials
2108
Conditions
173
Terminated since 2020
Browse by condition (2108 total)
- Heart failure 61 trialsAll Heart failure trials
- Breast cancer 55 trialsAll Breast cancer trials
- Prostate cancer 53 trialsAll Prostate cancer trials
- Diabetes mellitus, type 2 52 trialsAll Diabetes mellitus, type 2 trials
- Ulcerative colitis 44 trialsAll Ulcerative colitis trials
- Lung cancer 24 trialsAll Lung cancer trials
- Colorectal cancer 24 trialsAll Colorectal cancer trials
- Diabetes 24 trialsAll Diabetes trials
- Crohn's disease 16 trialsAll Crohn's disease trials
- Hypertension 15 trialsAll Hypertension trials
- Stage iv breast cancer ajcc v6 and v7 15 trialsAll Stage iv breast cancer ajcc v6 and v7 trials
- Stage iv lung cancer ajcc v8 15 trialsAll Stage iv lung cancer ajcc v8 trials
- Recurrent ovarian carcinoma 14 trialsAll Recurrent ovarian carcinoma trials
- Pain 14 trialsAll Pain trials
- All Unspecified adult solid tumor, protocol specific trials
- Crohn disease 13 trialsAll Crohn disease trials
- Non-small cell lung cancer 13 trialsAll Non-small cell lung cancer trials
- Asthma 13 trialsAll Asthma trials
- Lymphoma 13 trialsAll Lymphoma trials
- Recurrent breast carcinoma 13 trialsAll Recurrent breast carcinoma trials